Quarter Ended Sep 30, 2021
Net sales increased 14% to $114.7 million compared to $100.3 million
Net income was $5.5 million, or $0.24 per diluted share, compared to $7.2 million, or $0.34 per diluted share
Adjusted EBITDA increased 38% to $12.9 million compared to $9.4 million
For complete information regarding our financials, see our periodic filings.